Brokerages Set Healthpeak Properties, Inc. (NYSE:DOC) Target Price at $19.67

Healthpeak Properties, Inc. (NYSE:DOC) has been assigned an average recommendation of “Hold” from the thirteen research firms that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and six have issued a buy rating on the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $19.6667.

Several research firms have recently commented on DOC. Robert W. Baird cut their price target on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating for the company in a research note on Wednesday, November 12th. The Goldman Sachs Group began coverage on shares of Healthpeak Properties in a research report on Friday, January 9th. They set a “neutral” rating and a $17.00 price objective for the company. Evercore ISI reduced their target price on shares of Healthpeak Properties from $22.00 to $21.00 and set an “outperform” rating for the company in a research note on Monday, December 15th. Weiss Ratings upgraded shares of Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday. Finally, Cantor Fitzgerald set a $17.00 price target on shares of Healthpeak Properties in a report on Monday, January 5th.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. State Street Corp boosted its position in shares of Healthpeak Properties by 1.8% during the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock worth $947,889,000 after purchasing an additional 895,460 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Healthpeak Properties by 41.0% in the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after purchasing an additional 8,212,504 shares during the period. Geode Capital Management LLC lifted its stake in shares of Healthpeak Properties by 1.0% in the second quarter. Geode Capital Management LLC now owns 19,071,094 shares of the real estate investment trust’s stock valued at $332,625,000 after purchasing an additional 197,540 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in Healthpeak Properties by 2.8% during the second quarter. Charles Schwab Investment Management Inc. now owns 10,520,156 shares of the real estate investment trust’s stock worth $184,208,000 after buying an additional 282,155 shares in the last quarter. Finally, Cullen Capital Management LLC grew its position in Healthpeak Properties by 6.7% during the third quarter. Cullen Capital Management LLC now owns 10,232,875 shares of the real estate investment trust’s stock worth $195,960,000 after buying an additional 641,771 shares during the period. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

NYSE DOC opened at $17.74 on Friday. The firm has a market cap of $12.33 billion, a P/E ratio of -354.69, a P/E/G ratio of 4.54 and a beta of 1.12. Healthpeak Properties has a 52-week low of $15.71 and a 52-week high of $21.28. The business’s 50-day moving average price is $17.03 and its 200 day moving average price is $17.67. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 1.11.

Healthpeak Properties Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 6.9%. The ex-dividend date of this dividend is Tuesday, March 17th. Healthpeak Properties’s dividend payout ratio is -2,440.00%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.